Carteolol

Last Updated: 04/28/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 497 publications

Ocular adverse reactions associated with intraocular pressure-reducing drugs: An analysis of the FDA adverse event reporting system (FAERS).

Ocular adverse reactions associated with intraocular pressure-reducing drugs: An analysis of the FDA adverse event reporting system (FAERS).

Journal: The International journal of risk & safety in medicine
Published: January 02, 2026

Atrioventricular Block Caused by Carteolol Eye Drops Administered to Unilateral Eye or Bilateral Eyes: A Case Report.

Atrioventricular Block Caused by Carteolol Eye Drops Administered to Unilateral Eye or Bilateral Eyes: A Case Report.

Journal: Cureus
Published: August 13, 2025

Predicting compounds that interact with the 2 known agonist-induced conformations of the human β1-adrenoceptor.

Predicting compounds that interact with the 2 known agonist-induced conformations of the human β1-adrenoceptor.

Journal: Molecular pharmacology
Published: June 13, 2025

Computational repurposing of approved drugs targeting KRAS G12D and EGFR for colorectal cancer therapy.

Computational repurposing of approved drugs targeting KRAS G12D and EGFR for colorectal cancer therapy.

Journal: PloS one
Published: June 03, 2025

Drugs for open-angle glaucoma.

Drugs for open-angle glaucoma.

Journal: The Medical letter on drugs and therapeutics
Published: April 22, 2025

Efficacy of topical 2% carteolol in the treatment of infantile hemangiomas: a dermoscopic and clinical evaluation.

Efficacy of topical 2% carteolol in the treatment of infantile hemangiomas: a dermoscopic and clinical evaluation.

Journal: Archives of dermatological research
Published: January 29, 2025

0.01% atropine combined with carteolol hydrochloride can inhibit the scleral remodeling in guinea pigs with form-deprivation myopia.

0.01% atropine combined with carteolol hydrochloride can inhibit the scleral remodeling in guinea pigs with form-deprivation myopia.

Journal: Scientific reports
Published: December 03, 2024

Adrenaline enhances nociceptive and motor blockades by intrathecal carteolol and oxprenolol in rats.

Adrenaline enhances nociceptive and motor blockades by intrathecal carteolol and oxprenolol in rats.

Journal: Fundamental & clinical pharmacology
Published: October 10, 2024

A national analysis of systemic adverse events of beta-blockers used for glaucoma therapy.

A national analysis of systemic adverse events of beta-blockers used for glaucoma therapy.

Journal: Cutaneous and ocular toxicology
Published: September 12, 2024

Toward a personalized chronotherapy of blood pressure.

Toward a personalized chronotherapy of blood pressure.

Journal: Biomedical journal
Published: June 26, 2024

Timing and Efficacy Evaluation of 755-nm Long Pulse Alexandrite Laser and 2% Carteolol Hydrochloride Eye Drops Co-Treatment for Thicker Superficial Infantile Hemangioma.

Timing and Efficacy Evaluation of 755-nm Long Pulse Alexandrite Laser and 2% Carteolol Hydrochloride Eye Drops Co-Treatment for Thicker Superficial Infantile Hemangioma.

Journal: Clinical, cosmetic and investigational dermatology
Published: June 21, 2024

Genotypic and phenotypic analysis of an oculocutaneous albinism patient: a case report and review of the literature.

Genotypic and phenotypic analysis of an oculocutaneous albinism patient: a case report and review of the literature.

Journal: Journal of medical case reports
Published: May 06, 2024
Showing 1-12 of 497

Last Updated: 04/28/2026